Fuan Pharmaceutical's (SHE:300194) wholly-owned subsidiary, Fu'an Pharmaceutical Group Chongqing Bosheng Pharmaceutical, will invest 428 million yuan for the construction of an active pharmaceutical ingredient production base, according to a Shenzhen Stock Exchange filing on Wednesday.
The production base will produce 173.9 tons of raw materials every year.
The facility will include a production plant, a solid warehouse and an office building that will be built with estimated total construction area of 38,800 square meters, the pharmaceutical company said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。